Aplisens SA (APN) - Net Assets
Based on the latest financial reports, Aplisens SA (APN) has net assets worth zł227.07 Million PLN (≈ $62.49 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł239.54 Million ≈ $65.92 Million USD) and total liabilities (zł12.46 Million ≈ $3.43 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Aplisens SA's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł227.07 Million |
| % of Total Assets | 94.8% |
| Annual Growth Rate | 9.97% |
| 5-Year Change | 29.19% |
| 10-Year Change | 70.33% |
| Growth Volatility | 9.8 |
Aplisens SA - Net Assets Trend (2008–2024)
This chart illustrates how Aplisens SA's net assets have evolved over time, based on quarterly financial data. Also explore APN asset base for the complete picture of this company's asset base.
Annual Net Assets for Aplisens SA (2008–2024)
The table below shows the annual net assets of Aplisens SA from 2008 to 2024. For live valuation and market cap data, see how much is Aplisens SA worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł223.84 Million ≈ $61.60 Million |
+4.32% |
| 2023-12-31 | zł214.57 Million ≈ $59.05 Million |
+15.25% |
| 2022-12-31 | zł186.18 Million ≈ $51.24 Million |
+3.01% |
| 2021-12-31 | zł180.74 Million ≈ $49.74 Million |
+4.32% |
| 2020-12-31 | zł173.26 Million ≈ $47.68 Million |
+5.89% |
| 2019-12-31 | zł163.62 Million ≈ $45.03 Million |
+1.88% |
| 2018-12-31 | zł160.60 Million ≈ $44.20 Million |
+6.60% |
| 2017-12-31 | zł150.66 Million ≈ $41.46 Million |
+4.01% |
| 2016-12-31 | zł144.85 Million ≈ $39.87 Million |
+10.22% |
| 2015-12-31 | zł131.42 Million ≈ $36.17 Million |
+9.76% |
| 2014-12-31 | zł119.72 Million ≈ $32.95 Million |
-0.42% |
| 2013-12-31 | zł120.24 Million ≈ $33.09 Million |
+12.06% |
| 2012-12-31 | zł107.30 Million ≈ $29.53 Million |
+13.61% |
| 2011-12-31 | zł94.45 Million ≈ $25.99 Million |
+19.41% |
| 2010-12-31 | zł79.10 Million ≈ $21.77 Million |
+13.63% |
| 2009-12-31 | zł69.61 Million ≈ $19.16 Million |
+42.26% |
| 2008-12-31 | zł48.93 Million ≈ $13.47 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Aplisens SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1714.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł195.01 Million | 89.27% |
| Common Stock | zł2.23 Million | 1.02% |
| Other Comprehensive Income | zł2.08 Million | 0.95% |
| Other Components | zł19.13 Million | 8.76% |
| Total Equity | zł218.44 Million | 100.00% |
Aplisens SA Competitors by Market Cap
The table below lists competitors of Aplisens SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nebag ag
SW:NBEN
|
$55.67 Million |
|
Hoa Tho Textile - Garment Joint Stock Corp
VN:HTG
|
$55.67 Million |
|
Where Food Comes From Inc
NASDAQ:WFCF
|
$55.67 Million |
|
Libental
TA:LBTL
|
$55.69 Million |
|
NFON AG
XETRA:NFN
|
$55.60 Million |
|
Brimstone Investment Corporation Limited
JSE:BRN
|
$55.54 Million |
|
Finetechnix. Co.Ltd
KQ:106240
|
$55.53 Million |
|
Daekyo
KO:019680
|
$55.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aplisens SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 209,743,000 to 218,442,000, a change of 8,699,000 (4.1%).
- Net income of 20,743,000 contributed positively to equity growth.
- Dividend payments of 11,150,000 reduced retained earnings.
- Share repurchases of 7,984,000 reduced equity.
- New share issuances of 2,619,000 increased equity.
- Other comprehensive income increased equity by 808,000.
- Other factors increased equity by 3,663,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł20.74 Million | +9.5% |
| Dividends Paid | zł11.15 Million | -5.1% |
| Share Repurchases | zł7.98 Million | -3.65% |
| Share Issuances | zł2.62 Million | +1.2% |
| Other Comprehensive Income | zł808.00K | +0.37% |
| Other Changes | zł3.66 Million | +1.68% |
| Total Change | zł- | 4.15% |
Book Value vs Market Value Analysis
This analysis compares Aplisens SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.94x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.78x to 0.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | zł4.93 | zł18.65 | x |
| 2009-12-31 | zł5.89 | zł18.65 | x |
| 2010-12-31 | zł6.72 | zł18.65 | x |
| 2011-12-31 | zł7.32 | zł18.65 | x |
| 2012-12-31 | zł8.22 | zł18.65 | x |
| 2013-12-31 | zł8.94 | zł18.65 | x |
| 2014-12-31 | zł8.85 | zł18.65 | x |
| 2015-12-31 | zł10.08 | zł18.65 | x |
| 2016-12-31 | zł10.89 | zł18.65 | x |
| 2017-12-31 | zł11.61 | zł18.65 | x |
| 2018-12-31 | zł12.71 | zł18.65 | x |
| 2019-12-31 | zł13.00 | zł18.65 | x |
| 2020-12-31 | zł14.41 | zł18.65 | x |
| 2021-12-31 | zł15.13 | zł18.65 | x |
| 2022-12-31 | zł16.44 | zł18.65 | x |
| 2023-12-31 | zł19.27 | zł18.65 | x |
| 2024-12-31 | zł19.91 | zł18.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aplisens SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.50%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.35%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 1.08x
- Recent ROE (9.50%) is below the historical average (11.45%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 17.59% | 18.88% | 0.77x | 1.22x | zł3.68 Million |
| 2009 | 10.11% | 15.51% | 0.60x | 1.08x | zł76.70K |
| 2010 | 12.36% | 20.90% | 0.57x | 1.04x | zł1.86 Million |
| 2011 | 12.77% | 17.33% | 0.65x | 1.13x | zł2.61 Million |
| 2012 | 13.79% | 17.91% | 0.67x | 1.14x | zł4.03 Million |
| 2013 | 12.11% | 18.06% | 0.59x | 1.14x | zł2.52 Million |
| 2014 | 10.61% | 14.14% | 0.68x | 1.10x | zł722.50K |
| 2015 | 10.51% | 15.52% | 0.63x | 1.07x | zł665.40K |
| 2016 | 9.84% | 14.95% | 0.61x | 1.09x | zł-233.50K |
| 2017 | 13.20% | 19.68% | 0.62x | 1.08x | zł4.76 Million |
| 2018 | 9.04% | 13.55% | 0.61x | 1.10x | zł-1.52 Million |
| 2019 | 8.77% | 11.90% | 0.68x | 1.09x | zł-1.98 Million |
| 2020 | 8.48% | 13.38% | 0.59x | 1.07x | zł-2.59 Million |
| 2021 | 9.73% | 14.17% | 0.63x | 1.09x | zł-483.10K |
| 2022 | 11.20% | 13.83% | 0.73x | 1.11x | zł2.19 Million |
| 2023 | 15.07% | 19.37% | 0.70x | 1.11x | zł10.64 Million |
| 2024 | 9.50% | 13.35% | 0.66x | 1.08x | zł-1.10 Million |
Industry Comparison
This section compares Aplisens SA's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $79,652,159
- Average return on equity (ROE) among peers: 2.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aplisens SA (APN) | zł227.07 Million | 17.59% | 0.05x | $55.65 Million |
| PZ Cormay SA (CRM) | $174.15 Million | -2.96% | 0.30x | $12.84 Million |
| Introl S.A. (INL) | $99.78 Million | 14.88% | 0.37x | $51.22 Million |
| Sonel S.A. (SON) | $83.49 Million | 11.32% | 0.26x | $56.83 Million |
| Satis Group S.A. (STS) | $30.76 Million | -91.44% | 1.62x | $1.10 Million |
| Neptis (YAN) | $10.09 Million | 80.23% | 1.97x | $41.28 Million |
About Aplisens SA
Aplisens S.A. supplies industrial control and measurement equipment in Poland, European Union, CIS countries, the United States, Asia, and internationally. The company offers pressure, differential pressure, and level transducers; depth and level probes; electromagnetic flowmeters; measuring orifices; temperature sensors and transducers; valves and mounting accessories; meters, controllers, and d… Read more